Pfizer Inc. (PFE) is a household name that requires no introduction. Its skyrocketing sales of vaccines and the COVID-19 tablet have led it to witness solid growth over the past year. In addition, the company also sells a range of blockbuster drugs, such as blood thinners, breast cancer medications, arthritis treatments, and pneumonia vaccinations.
The stock has gained 32.2% over the past year and 21.9% over the past nine months to close yesterday’s trading session at $52.31.
